Navigation Links
Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
Date:1/13/2009

ICON Joins as Associate Member

WASHINGTON, Jan. 13 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policy makers and the public in the U.S. and worldwide, today announced that it has elected Dr. Derek Winstanly as Chair for 2009 and Mr. William Sharbaugh as Chair-Elect.

Dr. Winstanly, MBChB, Executive Vice President of Strategic Business Partnerships for Quintiles Transnational, and Mr. Sharbaugh, Chief Operating Officer of PPD, were elected at the association's annual meeting in December. Dr. Winstanly is a respected leader of the clinical research organization (CRO) industry, having held various global leadership positions within Quintiles since joining the company in 1999. In his current role, as Executive Vice President, he works with senior biopharmaceutical executives to provide long-term strategic solutions, and is responsible for the Office of the Chief Medical Officer as well as the ethics and quality assurance functions of the company.

Mr. Sharbaugh joined PPD in 2007 after spending more than 16 years in the pharmaceutical industry, including senior management positions with Bristol-Myers Squibb and Merck & Co. As COO, he provides strategic direction and leadership to PPD's Phase II-IV clinical business, global central labs, information technology and human resources.

"I am delighted to lead ACRO in 2009 and to help set the organization's strategic agenda during this crucial period of development for the CRO industry," said Dr. Winstanly. "The long-term future for the CRO industry remains bright and we look forward to working with our clients, regulators and legislators globally to bring about a more efficient drug development paradigm while maintaining the highest standards of patient safety."

ACRO is also pleased to announce the addition of ICON plc as an associate member. ICON, based in Dublin, Ireland, is a full service CRO that currently has more than 6,500 employees working in 38 countries.

"Dr. Winstanly and Mr. Sharbaugh bring tremendous vision and commitment to the ACRO leadership team," said ACRO Executive Director Doug Peddicord, Ph.D. "As one of the leading global CROs, we welcome ICON into the association and, as always, we will work to provide exceptional value for all of our members."

About ACRO

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. ACRO member companies employ more than 72,000 professionals worldwide. For more information, please visit www.acrohealth.org.


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
2. Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
5. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
6. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
7. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
8. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
9. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
10. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... --  The Harrington Discovery Institute at University ... has announced the 2017 recipients of Harrington Scholar-Innovator ... whose research shows promise to advance the standard ... – part of The Harrington Project for Discovery ... medicine: to advance early breakthroughs into the clinical ...
(Date:1/16/2017)... Jan. 16, 2017 When synthetic Fentanyl arrived on ... product as top-rate. They offered free samples, inviting would-be customers ... Soon, business was booming. ... 100 times more powerful than morphine, has racked up a ... last 2 years. One dealer,s recorded fentanyl sales reveals that ...
(Date:1/16/2017)... According to the new market research report "Display Controller Market by Type ... Controller), Application (Industrial Control, Medical Equipment, Automotive, Mobile Communication), and Geography - ... grow from USD 17.26 Billion in 2015 to reach USD 32.24 Billion ... Continue Reading ... ...
Breaking Medicine Technology:
(Date:1/15/2017)... ... January 15, 2017 , ... In this role, Courtney will be responsible ... the asthma & allergy friendly mark. This certification program was created by ASL and ... products to be more suitable for the 60+ million people living in the U.S. ...
(Date:1/15/2017)... ... 2017 , ... "On Tour is a music themed slideshow production package which ... Austin - CEO of Pixel Film Studios. , On Tour’s new slide presets ... animation of their slideshows. Place each slide on top of another slide or piece ...
(Date:1/15/2017)... ... January 15, 2017 , ... The ... is pleased to announce that it will be assisting HackensackUMC Mountainside with its ... Glen Ridge townships, servicing all surrounding towns. The firm will be working closely ...
(Date:1/14/2017)... ... January 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition which allows ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , TransFreeze ... transition from one clip to the next. , To use “Cut-Out First” presets, ...
(Date:1/13/2017)... ... January 13, 2017 , ... KOAMTAC ®, Inc., a leading manufacturer of ... generation companion scanner and data collector at the National Retail Federation’s Big Show (NRF17) ... an answer to the market’s need for more compact and rugged devices for collecting ...
Breaking Medicine News(10 mins):